Legend Biotech LEGN
NASDAQ LEGN
$19.89 +1.07 (+5.69%)
At close: Sep 30, 2026 · 4:00 PM EDT

Legend Biotech (LEGN) Share-based Compensation (IS) (2023 - 2025)

Updated

Legend Biotech's Share-based Compensation (IS) came in at $14.9 million for Q4 2025, up 11.2% from $13.4 million a year earlier.

Analysis

Legend Biotech (LEGN) Share-based Compensation (IS) (2023 - 2025) Analysis & Trends

For FY2025, Legend Biotech's Share-based Compensation (IS) was $64.6 million, down 6.2% from FY2024.

  • Going back by year, Share-based Compensation (IS) was $68.9 million in FY2024 (+44.5%) and $47.68 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Legend Biotech 3.67 Bn -74.25 Mn 251.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 14.90 Mn
Dec 31, 2024 13.40 Mn
Dec 31, 2023 12.59 Mn
API Access

Legend Biotech Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=LEGN&period=max&api_key=YOUR_API_KEY